AUG 21, 2014 06:45 AM PDT

Development and Applications of CRISPR-Cas9 for Genome Editing

C.E. CREDITS: CE | CEU
Speakers
  • Core Faculty Member, The Broad Institute of MIT/Harvard, Investigator, McGovern Institute for Brain Research, W.M. Keck Career Development Professor of Biomedical Engineering Assistant Profes
    Biography
      Feng Zhang is a Core Member of the Broad Institute of MIT and Harvard and the W. M. Keck Career Development Professor of Biomedical Engineering at MIT. As a graduate student at Stanford University, Zhang worked with advisor Karl Deisseroth to invent a set of technologies for dissecting the functional organization of brain circuits. His lab works on developing and applying disruptive technologies including optogenetics and genome engineering (TALEs and CRISPR) to understand nervous system function and disease. Zhang's long-term goal is to develop novel therapeutic strategies for disease treatment. He obtained a bachelor's degree from Harvard University and a PhD in chemistry and bioengineering from Stanford University. Before joining the MIT faculty he was a junior fellow of the Harvard University Society of Fellows. He is a recipient of the NSF's Alan T. Waterman Award, Perl/UNC Prize in Neuroscience, the NIH Director's Pioneer award, and awards from the Searle Scholars Program, McKnight, Keck, and Damon Runyon foundations.

    Abstract:

    The Cas9 endonuclease from the microbial adaptive immune system CRISPR can be easily programmed to bind or cleave specific DNA sequence using a short RNA guide. Cas9 is enabling the generation of more realistic disease models and is broadening the number of genetically-tractable organisms that can be used to study a variety of biological processes. The Cas9 nuclease can also be modified to modulate transcription, alter epigenetic states, and track the dynamics of chromatin in living cells. In this presentation we will look at the latest developments and applications of the Cas9 nuclease for understanding the function of the mammalian genome. We will also look at the on-going challenges as well as future prospects of the technology.


    Show Resources
    You May Also Like
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    MAY 02, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 02, 2018 08:00 AM PDT
    Immunohistochemistry protocols, which utilize antibodies to visualize proteins in tissue sections, have many steps that need optimized to prevent non-specific background effects, artifacts, o...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    Loading Comments...